Pediatric Hematology/Oncology

Rhabdomyosarcoma

Questions discussed in this category

Does the presence of anaplasia in embryonal rhabdomyosarcoma change your treatment approach?

What is the risk of serious bacterial infection in a febrile solid tumor patient who has not yet started cancer-directed therapy and has normal cell counts with no central line?

1 Answer available

How would you approach a patient with metastatic alveolar rhabdomyosarcoma with progression on first-line therapy?

1 Answer available

When should upfront molecular sequencing be performed in a pediatric or AYA patient with sarcoma?

1 Answer available

Is there utility in metronomic chemotherapy in adolescent and young adult patients with refractory sarcoma?

2 Answers available

How do you manage leptomeningeal disease in relapsed rhabdomyosarcoma?

FOXO1 translocation positive

1 Answer available

How do you manage newly diagnosed stage IV embryonal rhabdomyosarcoma?

Parameningeal disease with distant metastatic deposits to lymph nodes and lungs, fusion negative. What are the considerations for cyclophosphamide dos...

2 Answers available

How do you approach a patient with metastatic rhabdomyosarcoma complicated by sinusoidal obstruction syndrome (SOS) after neoadjuvant chemotherapy and radiation therapy?

Stage 4/group 4 due to dissemination in peritoneal fluid. Translocation negative; treated per intermediate risk protocol on study arm ARST1431 VAC/VI ...

1 Answer available

What is your therapy of choice for relapsed metastatic alveolar rhabdomyosarcoma?

If you had to recommend two options, one of which was palliation, what would your second option be?

1 Answer available

What treatment would you give to a pediatric patient with rhabdomyosarcoma in first relapse?

1 Answer available